January 16, 2017 by Mark Baumgartner and Chain Drug Review
Domenic Pilla, John Hammergren, Jürgen Schreiber, McKesson, McKesson Canada, Paul Julian, Rexall Health, Shoppers Drug Mart
2017, Issue 01-16-2017, Issues, News
TORONTO — Domenic Pilla has been appointed chief executive officer of McKesson Canada. Pilla now guides Canada’s largest distributor of pharmaceuticals and medical supplies and oversees the integration of Rexall Health, which McKesson Canada acquired in late December. McKesson Canada picked up about 470 retail pharmacies in the Rexall deal. Pilla reports to Paul Julian,
December 29, 2016 by Chain Drug Review
Daryl Katz, Domenic Pilla, John Hammergren, Jürgen Schreiber, Katz Group, McKesson, McKesson Canada, Paul Julian, Paula Keays, Rexall Health
Business, Featured Articles, Leading Headlines, Retail News
SAN FRANCISCO and TORONTO — McKesson Corp. has closed its $2.1 billion (U.S.) acquisition of Canadian drug chain Rexall Health and hired Domenic Pilla as chief executive officer of McKesson Canada. McKesson said late Wednesday that Pilla is slated to take the reins as McKesson Canada CEO on Jan. 3. In the role, he will
March 14, 2016 by Geoff Walden and Chain Drug Review
Alain Champagne, Daryl Katz, John Hammergren, Jürgen Schreiber, Katz Group, McKesson, McKesson Canada, Paul Julian, Rexall Health
2016, Issue 03-14-2016, Issues, News
TORONTO — McKesson Corp.’s $2.2 billion deal to acquire Rexall Health from Katz Group will strengthen the drug distributor’s position in Canada’s pharmaceutical supply chain. McKesson said the agreement is a natural next step for two companies that have worked together for over 20 years. In 2012, McKesson bought Katz’s 1,100-store banner operation covering I.D.A.,
March 2, 2016 by John Schultz and Chain Drug Review
Daryl Katz, John Hammergren, Jürgen Schreiber, Katz Group, McKesson, McKesson Canada, Paul Julian, Rexall Health
Business, Featured Articles, Leading Headlines, Retail News
SAN FRANCISCO and TORONTO — McKesson Corp. plans to acquire Canadian drug store operator Rexall Health from Katz Group for $2.2 billion ($3 billion Canadian). McKesson said Wednesday that the deal will strengthen its position in Canada’s pharmaceutical supply chain and is a natural step for the two companies, which have worked together for more
January 12, 2016 by Chain Drug Review
CVS Health, CVS/pharmacy, John Hammergren, McKesson, Omnicare, Rite Aid, Target Corp.
Business, Featured Articles, Leading Headlines, Pharmacy, Supplier News
SAN FRANCISCO — McKesson Corp. announced a new distribution pact with CVS Health for Target pharmacies in updating its earnings outlook for fiscal 2016 and providing preliminary guidance for fiscal 2017. McKesson said that for the 2016 fiscal year ending March 31, it now projects adjusted earnings per diluted share of $12.60 to $12.90, compared
September 28, 2015 by Brian Bossetta and Chain Drug Review
Albertsons, Bob Miller, John Hammergren, McKesson, pharmaceutical supply chain
2015, Issue 09-28-2015, Issues, News
SAN FRANCISCO and BOISE, Idaho — McKesson Corp. and Albertsons Cos. announced the signing of a five-year distribution agreement to include the sourcing and distribution of both branded and generic pharmaceuticals. As part of the agreement, which goes into effect April 1, 2016, Albertsons’ network of nearly 1,700 pharmacies will benefit from McKesson’s proprietary OneStop
September 16, 2015 by Chain Drug Review
Albertsons, Bob Miller, John Hammergren, McKesson, pharmaceutical distribution, Safeway
Business, Leading Headlines, Pharmacy, Retail News
SAN FRANCISCO and BOISE, Idaho — Food and drug retailer Albertsons has signed a five-year distribution pact for the sourcing and distribution of branded and generic drugs with McKesson Corp. The companies said late Tuesday that the pharmaceutical distribution agreement will go into effect on April 1, 2016. Boise-based Albertsons operates about 1,700 pharmacies in
July 6, 2015 by John Schultz and Chain Drug Review
chief information officer, chief technology officer, CIO, John Hammergren, Kathy McElligott, McKesson, Randy Spratt
2015, Issue 07-06-2015, Issues, News
SAN FRANCISCO — Kathy McElligott has been appointed executive vice president and chief information officer (CIO) and chief technology officer (CTO) at McKesson Corp. She comes to McKesson from Emerson, where she served as CIO since 2010 and managed Emerson’s information technology strategy and information security for its global operations. McElligott succeeds Randy Spratt, who
June 22, 2015 by Chain Drug Review and Chain Drug Review
chief information officer, chief technology officer, CIO, CTO, Emerson, John Hammergren, Kathy McElligott, McKesson, Randy Spratt
Business, Leading Headlines, Retail News, Supplier News
SAN FRANCISCO — Kathy McElligott is joining McKesson Corp. as executive vice president, chief information officer and chief technology officer. McKesson said Monday that McElligott, currently CIO at technology and engineering company Emerson, will start in the new post on July 20. She succeeds Randy Spratt, who is retiring after a 29-year career with McKesson.
June 9, 2015 by Chain Drug Review and Chain Drug Review
2015 Nexus Award for Lifetime Achievement, Center for Healthcare Supply Chain Research, HDMA, Healthcare Distribution Management Association, John Gray, John Hammergren, Karen Ribler, McKesson, Paul Julian
Leading Headlines, Pharmacy, Supplier News
ARLINGTON, Va. — McKesson Corp. executive Paul Julian has received the 2015 Nexus Award for Lifetime Achievement from the Healthcare Distribution Management Association’s Center for Healthcare Supply Chain Research and Genentech Inc. HDMA said Tuesday that Julian, executive vice president and group president at McKesson, was presented the award this week at the 2015 HDMA
March 16, 2015 by Chain Drug Review
Bansi Nagji, Brian Tyler, Celesio, John Hammergren, McKesson, Paul Julian, pharmaceutical distribution
2015, Issue 03-16-2015, News
SAN FRANCISCO — Brian Tyler has been promoted to president of North American pharmaceutical distribution and services at McKesson Corp. The company also has hired Bansi Nagji to take over Tyler’s previous post as executive vice president of corporate strategy and business development. As president of North American pharmaceutical distribution, Tyler takes on a new
February 18, 2014 by Chain Drug Review
Alliance Boots, AmerisourceBergen, brand-name drugs, Cardinal Health, Celesio, CVS Caremark, drug chain, drug distribution, drug wholesalers, generic drug sourcing, generic pharmaceuticals, John Hammergren, John Standley, McKesson, Rite Aid, Walgreens
Pharmacy, Retail News
CAMP HILL, Pa. — Rite Aid Corp. and McKesson Corp. have expanded their distribution agreement to cover a longer time frame and include both generic and brand-name drugs. The companies said Tuesday that the new five-year agreement runs to March 2019. The deal marks a second extension of Rite Aid and McKesson’s primary distribution relationship.
January 31, 2012 by Chain Drug Review
Daryl Katz, Dell Pharmacies, Drug Trading Co., John Hammergren, Katz Group Canada, McKesson, Medicine Shoppe Canada, ProPharm, Rexall
Business, Retail News
TORONTO — Katz Group Canada has signed an agreement to sell Drug Trading Co., its banner pharmacy business, and Medicine Shoppe Canada, its franchise pharmacy business, to McKesson Corp. for about $920 million. As part of the transaction McKesson is entering into other ancillary agreements with Katz Group. Both Drug Trading and Medicine Shoppe Canada